According to Pear Therapeutics's latest financial reports the company has $59.27 Million USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $59.27 M | -66.05% |
2021-12-31 | $0.17 B | 40.29% |
2020-12-31 | $0.12 B | 19.13% |
2019-12-31 | $0.10 B |